Beijing, China

Shuming Wang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2011-2024

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations of Shuming Wang

Introduction

Shuming Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of display technology and pharmaceuticals. With a total of four patents to his name, Wang's work showcases his innovative spirit and dedication to advancing technology.

Latest Patents

Wang's latest patents include a display panel that features a plurality of support bars with ends that sequentially decrease in length from a frame area to a display area. This invention aims to enhance the structural integrity and visual performance of display devices. Another significant patent involves ribofuranosyl purine compounds, which are designed for the treatment of diseases associated with platelet aggregation. This invention includes methods for preparing these compounds and their use in pharmaceutical formulations.

Career Highlights

Throughout his career, Shuming Wang has worked with prominent companies such as Jiangsu Kangbeide Pharmaceuticals Co. Ltd. and Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Wang has collaborated with several professionals in his field, including Huiyong Xue and Li Wang. These collaborations have contributed to the successful development of his patents and innovations.

Conclusion

Shuming Wang's contributions to technology and pharmaceuticals highlight his role as a leading inventor. His innovative patents reflect his commitment to improving existing technologies and addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…